NO973589L - Medikament for behandling av tvangstanke-tvangshandlingsproblemer, sövnapne, seksuelle funksjonsforstyrrelser, emesi og reisesyke - Google Patents

Medikament for behandling av tvangstanke-tvangshandlingsproblemer, sövnapne, seksuelle funksjonsforstyrrelser, emesi og reisesyke

Info

Publication number
NO973589L
NO973589L NO973589A NO973589A NO973589L NO 973589 L NO973589 L NO 973589L NO 973589 A NO973589 A NO 973589A NO 973589 A NO973589 A NO 973589A NO 973589 L NO973589 L NO 973589L
Authority
NO
Norway
Prior art keywords
emesis
obsessive
treatment
sleep apnea
sexual dysfunction
Prior art date
Application number
NO973589A
Other languages
English (en)
Norwegian (no)
Other versions
NO973589D0 (no
Inventor
Jordi Frigola Constansa
Original Assignee
Esteve Labor Dr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Labor Dr filed Critical Esteve Labor Dr
Publication of NO973589D0 publication Critical patent/NO973589D0/no
Publication of NO973589L publication Critical patent/NO973589L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO973589A 1995-12-12 1997-08-04 Medikament for behandling av tvangstanke-tvangshandlingsproblemer, sövnapne, seksuelle funksjonsforstyrrelser, emesi og reisesyke NO973589L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9514690A FR2742052B1 (fr) 1995-12-12 1995-12-12 Utilisation des derives 1-(4-(4-aryl (ou heteroaryl)-1-piper azinyl)-buty)-1h-azole pour le traitement de la depression, des troubles obsessifs compulsifs, l'apnee du sommeil, les dysfonctions sexuelles, l'emese et le mal des transports
PCT/EP1996/005736 WO1997021439A1 (fr) 1995-12-12 1996-12-11 Medicament destine au traitement des troubles obsessifs compulsifs, de l'apnee du sommeil, des dysfonctions sexuelles, de l'emese et du mal des transports

Publications (2)

Publication Number Publication Date
NO973589D0 NO973589D0 (no) 1997-08-04
NO973589L true NO973589L (no) 1997-10-08

Family

ID=9485400

Family Applications (1)

Application Number Title Priority Date Filing Date
NO973589A NO973589L (no) 1995-12-12 1997-08-04 Medikament for behandling av tvangstanke-tvangshandlingsproblemer, sövnapne, seksuelle funksjonsforstyrrelser, emesi og reisesyke

Country Status (16)

Country Link
EP (1) EP0808166A1 (de)
JP (1) JPH11501051A (de)
CN (1) CN1177297A (de)
AR (1) AR004378A1 (de)
AU (1) AU716665B2 (de)
CA (1) CA2211161A1 (de)
CZ (1) CZ255197A3 (de)
ES (1) ES2134709B1 (de)
FR (1) FR2742052B1 (de)
HU (1) HUP9800198A2 (de)
IL (1) IL121461A0 (de)
NO (1) NO973589L (de)
PL (1) PL321779A1 (de)
TR (1) TR199700794T1 (de)
WO (1) WO1997021439A1 (de)
ZA (1) ZA9610457B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2763950B1 (fr) * 1997-06-02 2002-09-20 Esteve Labor Dr 2- {4- [4-(4,5-dichloro-2-methylimidazol-1-yl)butyl] -1- piperazinyl }-5-fluoropyrimidine, sa preparation et son utilisation therapeutique
TW526202B (en) * 1998-11-27 2003-04-01 Shionogi & Amp Co Broad spectrum cephem having benzo[4,5-b]pyridium methyl group of antibiotic activity
US6046331A (en) * 1998-12-17 2000-04-04 Synaptic Pharmaceutical Corporation Imidazolones and their use in treating benign prostatic hyperplasia and other disorders
WO2002014314A2 (en) 2000-08-14 2002-02-21 Ortho Mcneil Pharmaceutical, Inc. Substituted pyrazoles
US7332494B2 (en) 2000-08-14 2008-02-19 Janssen Pharmaceutica, N.V. Method for treating allergies using substituted pyrazoles
NZ524192A (en) 2000-08-14 2005-02-25 Ortho Mcneil Pharm Inc Substituted pyrazoles
US6953793B2 (en) 2000-08-14 2005-10-11 Ortho-Mcneil Pharmaceutical, Inc. Substituted pyrazoles
WO2002020002A2 (en) 2000-09-06 2002-03-14 Ortho Mcneil Pharmaceutical, Inc. A method for treating allergies
WO2005030148A2 (en) 2003-09-25 2005-04-07 Cenomed, Inc. Tetrahydroindolone derivatives for treatment of neurological conditions
WO2005094827A1 (en) * 2004-03-30 2005-10-13 Kestrel Pharmaceuticals Inc. Methods for treating sexual dysfunction
CA2606471C (en) * 2005-04-26 2014-02-11 Hypnion, Inc. Benzisoxazole piperidine compounds and methods of use thereof
WO2006116615A1 (en) 2005-04-26 2006-11-02 Hypnion, Inc. Benzisoxazole piperazine compounds and methods of use thereof
GB2435827A (en) * 2006-03-09 2007-09-12 Del Dr Esteve S A Spain Lab Use of substituted piperazine compounds for the treatment of food related disorders
CN115304590B (zh) * 2022-09-19 2024-05-28 皮摩尔新药(辽宁)有限公司 2h-苯并三氮唑衍生物及其制备方法及含有它们的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2672052B1 (fr) * 1991-01-28 1995-05-24 Esteve Labor Dr Derives d'aryl (ou heteroaryl)-piperazinyl-alkyl-azoles, leur preparation et leur application en tant que medicaments.
FR2723091B1 (fr) * 1994-07-29 1996-11-08 Esteve Labor Dr Tetrahydropyridine-(6,4-hydroxypiperidine) alkylazoles

Also Published As

Publication number Publication date
CN1177297A (zh) 1998-03-25
PL321779A1 (en) 1997-12-22
IL121461A0 (en) 1998-02-08
CZ255197A3 (cs) 1998-01-14
CA2211161A1 (fr) 1997-06-19
ZA9610457B (en) 1997-06-24
FR2742052A1 (fr) 1997-06-13
JPH11501051A (ja) 1999-01-26
NO973589D0 (no) 1997-08-04
TR199700794T1 (xx) 1997-11-21
MX9706133A (es) 1997-11-29
HUP9800198A2 (hu) 1999-09-28
AU1376497A (en) 1997-07-03
AR004378A1 (es) 1998-11-04
EP0808166A1 (de) 1997-11-26
WO1997021439A1 (fr) 1997-06-19
ES2134709A1 (es) 1999-10-01
ES2134709B1 (es) 2000-05-16
FR2742052B1 (fr) 1998-04-10
AU716665B2 (en) 2000-03-02

Similar Documents

Publication Publication Date Title
NO973589L (no) Medikament for behandling av tvangstanke-tvangshandlingsproblemer, sövnapne, seksuelle funksjonsforstyrrelser, emesi og reisesyke
GEP20043269B (en) Purine Derivatives, Method for Their Production and Composition Containing the Same
EP0513702A3 (de) Melatoninderivate zur Behandlung von Schlafstörungen und zur Pre-Anästhesie
MA27702A1 (fr) Preparation de suspensions aqueuses steriles comprenant des ingredients actifs cristallins micronises, destinees a l'inhalation
RO117145B1 (ro) Emulsie sau soluţie apoasă, mucoadezivă
DE69400435T2 (de) Verwendung von carbamazepine und oxcarbazepine zur behandlung von parkinson und den parkinson-syndromen
BG101118A (en) Therapeutical compounds
NO20055880L (no) Memantin orale doseringsformer
DE122006000057I2 (de) Proteinhaltige arzneimittel
PT1067934E (pt) Solucao anti-depressiva liquida oral
BR9612287A (pt) Emprego de inibidores de troca de na+ /h+ (nhe) celular para a preparação de um medicamento para estimular a respiração
ES2089974A1 (es) Utilizacion de los derivados de 1-(4-)4-aril (o heteroaril)-1-piperazinil)-butil)-1-h-azol para la preparacion de medicamentos destinados al tratamiento de los trastornos de la secrecion gastrica.
NO20015228D0 (no) Anvendelse av saredutant og de farmasöytisk aksepterbare salter derav for fremstilling av medikamenter anvendt for åbehandle eller forebygge sinnslidelser, tilpasningslidelser ellerblandede angst-depresjonslidelser
EP1393738A4 (de) Arzneimittel gegen diabetes
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
BR0009080A (pt) Método de tratamento da apnéia do sono
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
MXPA02011533A (es) Nuevas formulaciones de alfa-2,4-disulfofenil-n-terc-butilnitrona.
DE69211639D1 (de) Neue verbindungen und deren medizinale verwendung
RU2004112422A (ru) Роувастатин в преддеменционных состояниях
SE9000207D0 (sv) Laekemedel samt anvaendningen av detsamma
HUP0002905A2 (hu) 2-{4-[4-(4,5-Diklór-2-metilimidazol-1-il)butil]1-1piperazinil}-5-fluorpirimidin, előállítása és gyógyászati alkalmazása
ATE319452T1 (de) Arzneimittel gegen essstörungen
IT1299699B1 (it) Struttura perfezionata di carrozzina pieghevole, particolarmente per la movimentazione dell'invalido.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application